Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-011005
Filing Date
2020-06-11
Accepted
2020-06-11 16:16:19
Documents
45
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 447400
2 ex31-1.htm EX-31.1 19550
3 ex31-2.htm EX-31.2 19625
4 ex32-1.htm EX-32.1 8505
5 ex32-2.htm EX-32.2 8577
  Complete submission text file 0001493152-20-011005.txt   2353455

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pure-20200430.xml EX-101.INS 295196
7 XBRL SCHEMA FILE pure-20200430.xsd EX-101.SCH 31816
8 XBRL CALCULATION FILE pure-20200430_cal.xml EX-101.CAL 34479
9 XBRL DEFINITION FILE pure-20200430_def.xml EX-101.DEF 94515
10 XBRL LABEL FILE pure-20200430_lab.xml EX-101.LAB 243018
11 XBRL PRESENTATION FILE pure-20200430_pre.xml EX-101.PRE 168749
Mailing Address 9669 HERMOSA AVENUE RANCHO CUCAMONGA CA 91730
Business Address 9669 HERMOSA AVENUE RANCHO CUCAMONGA CA 91730 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-14468 | Film No.: 20957356
SIC: 2890 Miscellaneous Chemical Products